@stales At least two hugely important Rare drug development incentives under threat: accelerated approval and orphan Drug tax credit. People don’t understand that without these, a lot of R and D goes away….these incentives work! #CTSM
@stales@Medidata Managing and living with rare disease takes a lot of energy, time, money, and grit. Caregivers and patients need more support and society needs to be educated #CTSM
@stales@Medidata Many rare disease patients are kids who can’t advocate for themselves. Parents, extended family, teachers, clergy, and POLITICIANS are among the many that can speak on their behalf. #CTSM